The Cooper Companies, Inc. (NASDAQ:COO) Given Average Rating of “Moderate Buy” by Brokerages

The Cooper Companies, Inc. (NASDAQ:COO) has been assigned a consensus rating of “Moderate Buy” from the seventeen research firms that are presently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $90.7857.

Several research firms recently weighed in on COO. JPMorgan Chase & Co. raised their price target on shares of Cooper Companies from $66.00 to $78.00 and gave the stock a “neutral” rating in a research report on Friday, December 5th. KeyCorp restated a “sector weight” rating on shares of Cooper Companies in a research report on Friday, December 5th. Robert W. Baird raised their target price on shares of Cooper Companies from $85.00 to $98.00 and gave the stock an “outperform” rating in a report on Friday, December 5th. Weiss Ratings upgraded shares of Cooper Companies from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, January 12th. Finally, The Goldman Sachs Group reiterated a “sell” rating and issued a $73.00 price target on shares of Cooper Companies in a research note on Friday, January 9th.

Cooper Companies Price Performance

NASDAQ:COO opened at $75.82 on Tuesday. The stock has a market capitalization of $14.79 billion, a PE ratio of 37.53, a P/E/G ratio of 2.13 and a beta of 1.02. The company has a current ratio of 1.34, a quick ratio of 0.79 and a debt-to-equity ratio of 0.22. The firm has a fifty day simple moving average of $81.98 and a 200 day simple moving average of $76.02. Cooper Companies has a 1-year low of $61.78 and a 1-year high of $89.83.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share for the quarter, beating analysts’ consensus estimates of $1.03 by $0.07. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The business had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1.02 billion. During the same quarter in the prior year, the business earned $0.92 EPS. The firm’s revenue for the quarter was up 6.2% on a year-over-year basis. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. On average, research analysts expect that Cooper Companies will post 3.98 EPS for the current fiscal year.

Insider Buying and Selling

In related news, insider Holly R. Sheffield bought 1,230 shares of the company’s stock in a transaction dated Tuesday, December 16th. The stock was purchased at an average price of $80.75 per share, with a total value of $99,322.50. Following the completion of the acquisition, the insider owned 39,052 shares of the company’s stock, valued at $3,153,449. The trade was a 3.25% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Cynthia L. Lucchese purchased 1,784 shares of Cooper Companies stock in a transaction dated Monday, December 22nd. The stock was bought at an average price of $84.06 per share, for a total transaction of $149,963.04. Following the completion of the purchase, the director owned 9,445 shares in the company, valued at $793,946.70. This represents a 23.29% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In the last ninety days, insiders acquired 16,014 shares of company stock worth $1,304,416. 2.08% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of COO. Vanguard Group Inc. grew its holdings in shares of Cooper Companies by 1.8% during the second quarter. Vanguard Group Inc. now owns 24,254,677 shares of the medical device company’s stock worth $1,725,963,000 after purchasing an additional 421,423 shares during the last quarter. Capital World Investors raised its holdings in Cooper Companies by 25.7% in the 3rd quarter. Capital World Investors now owns 10,551,592 shares of the medical device company’s stock valued at $723,417,000 after buying an additional 2,159,233 shares during the last quarter. State Street Corp boosted its position in Cooper Companies by 2.4% during the 4th quarter. State Street Corp now owns 8,793,747 shares of the medical device company’s stock worth $720,736,000 after buying an additional 207,195 shares during the period. Wellington Management Group LLP boosted its position in Cooper Companies by 332.9% during the 3rd quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock worth $424,043,000 after buying an additional 4,756,178 shares during the period. Finally, Price T Rowe Associates Inc. MD grew its holdings in Cooper Companies by 58.8% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock worth $494,123,000 after acquiring an additional 2,231,568 shares during the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.